- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 9 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
NAG-NAG-BMA-MAN-MAN.2: 9 residues within 4Å:- Chain B: Y.28, G.29, H.30, Q.64, F.65, G.66
- Chain C: N.255, F.256, T.257
1 PLIP interactions:1 interactions with chain B- Hydrogen bonds: B:G.29
NAG-NAG-BMA-MAN-MAN.9: 9 residues within 4Å:- Chain F: Y.28, G.29, H.30, Q.64, F.65, G.66
- Chain G: N.255, F.256, T.257
1 PLIP interactions:1 interactions with chain F- Hydrogen bonds: F:G.29
NAG-NAG-BMA-MAN-MAN.16: 9 residues within 4Å:- Chain J: Y.28, G.29, H.30, Q.64, F.65, G.66
- Chain K: N.255, F.256, T.257
1 PLIP interactions:1 interactions with chain J- Hydrogen bonds: J:G.29
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG-NAG.4: 4 residues within 4Å:- Chain C: Q.340, T.365, Q.366, N.369
No protein-ligand interaction detected (PLIP)NAG-NAG.6: 3 residues within 4Å:- Chain C: E.55, N.208, N.220
No protein-ligand interaction detected (PLIP)NAG-NAG.7: 4 residues within 4Å:- Chain C: E.59, N.60
- Chain D: G.17, S.18
No protein-ligand interaction detected (PLIP)NAG-NAG.11: 4 residues within 4Å:- Chain G: Q.340, T.365, Q.366, N.369
No protein-ligand interaction detected (PLIP)NAG-NAG.13: 3 residues within 4Å:- Chain G: E.55, N.208, N.220
No protein-ligand interaction detected (PLIP)NAG-NAG.14: 4 residues within 4Å:- Chain G: E.59, N.60
- Chain H: G.17, S.18
No protein-ligand interaction detected (PLIP)NAG-NAG.18: 4 residues within 4Å:- Chain K: Q.340, T.365, Q.366, N.369
No protein-ligand interaction detected (PLIP)NAG-NAG.20: 3 residues within 4Å:- Chain K: E.55, N.208, N.220
No protein-ligand interaction detected (PLIP)NAG-NAG.21: 4 residues within 4Å:- Chain K: E.59, N.60
- Chain L: G.17, S.18
No protein-ligand interaction detected (PLIP)- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
NAG.22: 2 residues within 4Å:- Chain C: N.373, D.374
Ligand excluded by PLIPNAG.23: 4 residues within 4Å:- Chain C: V.272, S.418, S.419, N.420
Ligand excluded by PLIPNAG.24: 2 residues within 4Å:- Chain C: N.435, K.436
Ligand excluded by PLIPNAG.25: 4 residues within 4Å:- Chain C: K.211, F.212, N.213, T.215
Ligand excluded by PLIPNAG.26: 4 residues within 4Å:- Chain C: V.159, R.171, L.172, N.176
Ligand excluded by PLIPNAG.27: 1 residues within 4Å:- Chain D: N.115
Ligand excluded by PLIPNAG.28: 2 residues within 4Å:- Chain G: N.373, D.374
Ligand excluded by PLIPNAG.29: 4 residues within 4Å:- Chain G: V.272, S.418, S.419, N.420
Ligand excluded by PLIPNAG.30: 2 residues within 4Å:- Chain G: N.435, K.436
Ligand excluded by PLIPNAG.31: 4 residues within 4Å:- Chain G: K.211, F.212, N.213, T.215
Ligand excluded by PLIPNAG.32: 4 residues within 4Å:- Chain G: V.159, R.171, L.172, N.176
Ligand excluded by PLIPNAG.33: 1 residues within 4Å:- Chain H: N.115
Ligand excluded by PLIPNAG.34: 2 residues within 4Å:- Chain K: N.373, D.374
Ligand excluded by PLIPNAG.35: 4 residues within 4Å:- Chain K: V.272, S.418, S.419, N.420
Ligand excluded by PLIPNAG.36: 2 residues within 4Å:- Chain K: N.435, K.436
Ligand excluded by PLIPNAG.37: 4 residues within 4Å:- Chain K: K.211, F.212, N.213, T.215
Ligand excluded by PLIPNAG.38: 4 residues within 4Å:- Chain K: V.159, R.171, L.172, N.176
Ligand excluded by PLIPNAG.39: 1 residues within 4Å:- Chain L: N.115
Ligand excluded by PLIP- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schorcht, A. et al., Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers. J.Virol. (2020)
- Release Date
- 2020-09-23
- Peptides
- PGV04 heavy chain: AEI
PGV04 light chain: BFJ
AMC009 SOSIP.v4.2 envelope glycoprotein gp120: CGK
AMC009 SOSIP.v4.2 envelope glycoprotein gp41: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HE
GI
IB
LF
JJ
KC
AG
CK
DD
BH
EL
F
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- hetero-3-3-3-3-mer
- Ligands
- 9 x NAG- NAG- BMA: beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 3 x NAG- NAG- BMA- MAN- MAN: alpha-D-mannopyranose-(1-3)-[alpha-D-mannopyranose-(1-6)]beta-D-mannopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose
- 9 x NAG- NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose-(1-4)-2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- 18 x NAG: 2-acetamido-2-deoxy-beta-D-glucopyranose(Post Translational Modification)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Schorcht, A. et al., Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers. J.Virol. (2020)
- Release Date
- 2020-09-23
- Peptides
- PGV04 heavy chain: AEI
PGV04 light chain: BFJ
AMC009 SOSIP.v4.2 envelope glycoprotein gp120: CGK
AMC009 SOSIP.v4.2 envelope glycoprotein gp41: DHL - SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
HE
GI
IB
LF
JJ
KC
AG
CK
DD
BH
EL
F